Literature DB >> 12801454

When to order cardiovascular magnetic resonance in adults with congenital heart disease.

Sonya V Babu-Narayan1, Philip J Kilner, Michael A Gatzoulis.   

Abstract

Cardiovascular magnetic resonance (CMR), where available, contributes to the informed management of patients with congenital heart disease. In contrast to echocardiography, CMR becomes easier as patients grow. It is versatile and gives unrestricted access to the heart and intrathoracic vessels, providing functional and structural information. Its relative strengths are discussed, and examples are given of congenital conditions in which it provides clinically important information. CMR can prevent the need for diagnostic catheterization or expedite intervention if indicated, enabling planned, directed procedures. In our practice, CMR is used for serial follow-up, investigation of altered symptoms or signs, planning of transcatheter or surgical interventions, and for baseline assessment after surgery. As CMR becomes more widely available, it will contribute increasingly to the lifelong management of patients with congenital heart disease.

Entities:  

Mesh:

Year:  2003        PMID: 12801454     DOI: 10.1007/s11886-003-0070-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  22 in total

Review 1.  Clinical applications of cardiac magnetic resonance imaging after repair of tetralogy of Fallot.

Authors:  W A Helbing; A de Roos
Journal:  Pediatr Cardiol       Date:  2000 Jan-Feb       Impact factor: 1.655

2.  A simplified approach for assessment of intracardiac baffles and extracardiac conduits in congenital heart surgery with two- and three-dimensional magnetic resonance imaging.

Authors:  M A Fogel; A Hubbard; P M Weinberg
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

Review 3.  CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I.

Authors:  J Therrien; A Dore; W Gersony; L Iserin; R Liberthson; F Meijboom; J M Colman; E Oechslin; D Taylor; J Perloff; J Somerville; G D Webb
Journal:  Can J Cardiol       Date:  2001-09       Impact factor: 5.223

Review 4.  Myocardial perfusion imaging by magnetic resonance imaging.

Authors:  Katherine C Wu
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

5.  Coronary magnetic resonance angiography for the detection of coronary stenoses.

Authors:  W Y Kim; P G Danias; M Stuber; S D Flamm; S Plein; E Nagel; S E Langerak; O M Weber; E M Pedersen; M Schmidt; R M Botnar; W J Manning
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

6.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging.

Authors:  C H Lorenz; E S Walker; V L Morgan; S S Klein; T P Graham
Journal:  J Cardiovasc Magn Reson       Date:  1999       Impact factor: 5.364

Review 7.  Evaluation of congenital heart disease by magnetic resonance imaging.

Authors:  A de Roos; A A Roest
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

8.  Double-chambered right ventricle or sub-infundibular stenosis assessed by cardiovascular magnetic resonance.

Authors:  Philip J Kilner; Burkhard Sievers; Gerd P Meyer; S Yen Ho
Journal:  J Cardiovasc Magn Reson       Date:  2002       Impact factor: 5.364

9.  Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography.

Authors:  Tal Geva; Gerald F Greil; Audrey C Marshall; Michael Landzberg; Andrew J Powell
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

10.  Right ventricular performance and mass by use of cine MRI late after atrial repair of transposition of the great arteries.

Authors:  C H Lorenz; E S Walker; T P Graham; T A Powers
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

View more
  1 in total

Review 1.  The right ventricle in congenital heart disease.

Authors:  P A Davlouros; K Niwa; G Webb; M A Gatzoulis
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.